On this page, we present all of the funds holding GENE from our database of 13F filers, detailed in the table below. The first column indicates the name of each of the funds holding GENE, with a link to that fund's top holdings. The next columns indicate the amount of GENE stock held by each of the funds holding GENE, followed by the GENE position size held by the fund, and lastly the date of the quarterly filing period the data represents. In total, we count 4 funds holding GENE within the last two filing periods in our coverage universe of 13F filers, with the largest position size having been reported by Morgan Stanley. For more details on the positions held by Morgan Stanley (or by any of the other funds holding GENE), click the fund name in the "Holder" column of the funds-holding-GENE table below.
Holder | Amount | Position Size ($ in 1000's) | As of |
---|---|---|---|
Morgan Stanley | 17,289 | $41 | 12/31/2023 |
GENE | 17,289 | $41 | 12/31/2023 |
Rhumbline Advisers | 3,739 | $9 | 12/31/2023 |
GENE | 3,739 | $9 | 12/31/2023 |
UBS Group AG | 2,994 | $7 | 12/31/2023 |
GENE | 2,994 | $7 | 12/31/2023 |
Proequities Inc. | $0 | 03/31/2024 | |
Put | 0 | $0 | 03/31/2024 |
Call | 0 | $0 | 03/31/2024 |
GENE | 0 | $0 | 03/31/2024 |
Wells Fargo & Company MN | 130 | $0 | 12/31/2023 |
GENE | 130 | $0 | 12/31/2023 |
See Summary: Institutional Holders of GENE
See Details: Top 10 Hedge Funds Holding GENE
Free GENE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |